Revolutionizing Asset and Clinical Programs: Harnessing AI and GenAI Innovations for Individual Study Success
Pharmaceutical and biotech companies are increasingly using generative artificial intelligence (GenAI) to enhance clinical trials and drug development. This technology streamlines decision-making by automating manual documentation processes and reducing administrative burdens for research teams. Machine learning experts are collaborating with trial sponsors to leverage GenAI, creating a powerful team of AI models that provide deeper ...
